Medicover AB (MCOV B) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Medicover AB

Ambea AB

Humana AB

AddLife AB

Bonzun AB

Why is Medicover AB ?

Healthy long term growth as Net Sales has grown by an annual rate of 21.47%

With a growth in Net Profit of 188.7%, the company declared Very Positive results in Jun 25

The company has declared positive results for the last 5 consecutive quarters
OPERATING CASH FLOW(Y) Highest at SEK 2,521.44 MM
PRE-TAX PROFIT(Q) At SEK 283.83 MM has Grown at 177.12%
ROCE(HY) Highest at 8.87%

With ROE of 12.45%, it has a fair valuation with a 7.38 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 27.62%, its profits have risen by 155.1% ; the PEG ratio of the company is 0.4

Market Beating Performance

The stock has generated a return of 27.62% in the last 1 year, much higher than market (OMX Stockholm 30) returns of 8.01%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Medicover AB should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medicover AB for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Medicover AB

27.62%

0.54

30.11%

OMX Stockholm 30

8.01%

0.44

18.11%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

21.47%

EBIT Growth (5y)

29.36%

EBIT to Interest (avg)

3.30

Debt to EBITDA (avg)

1.57

Net Debt to Equity (avg)

1.35

Sales to Capital Employed (avg)

1.64

Tax Ratio

28.27%

Dividend Payout Ratio

129.11%

Pledged Shares

Institutional Holding

0.18%

ROCE (avg)

11.54%

ROE (avg)

9.18%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.38

EV to EBIT

33.60

EV to EBITDA

12.22

EV to Capital Employed

3.25

EV to Sales

1.89

PEG Ratio

0.39

Dividend Yield

0.03%

ROCE (Latest)

9.68%

ROE (Latest)

12.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 2,521.44 MM

PRE-TAX PROFIT(Q)

At SEK 283.83 MM has Grown at 177.12%

ROCE(HY)

Highest at 8.87%

INVENTORY TURNOVER RATIO(HY)

Highest at 28.03%

NET SALES(Q)

Highest at SEK 6,538.97 MM

INTEREST COVERAGE RATIO(Q)

Highest at 589.7

NET PROFIT(Q)

At SEK 217.96 MM has Grown at 175.18%

RAW MATERIAL COST(Y)

Fallen by -10.89% (YoY

OPERATING PROFIT(Q)

Highest at SEK 1,066.27 MM

-2What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 277.51 %

Here's what is working for Medicover AB

Pre-Tax Profit

At SEK 283.83 MM has Grown at 177.12%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Operating Cash Flow

Highest at SEK 2,521.44 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Sales

Highest at SEK 6,538.97 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (SEK MM)

Interest Coverage Ratio

Highest at 589.7

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Profit

At SEK 217.96 MM has Grown at 175.18%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (SEK MM)

Inventory Turnover Ratio

Highest at 28.03% and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Profit

Highest at SEK 1,066.27 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Raw Material Cost

Fallen by -10.89% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medicover AB

Debt-Equity Ratio

Highest at 277.51 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio